Received Aug 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Autoimmune diseases; This is a spontaneous report received from a consumer. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Tick fever" (ongoing); "Alpha gal" (ongoing). The patient's concomitant medications were not reported. The following information was reported: AUTOIMMUNE DISORDER (medically significant), outcome "unknown", described as "Autoimmune diseases". When COVID came out, the patient kept thinking she will just keep getting COVID over and over. The patient had tick fever around 2 years before he/she was finally diagnosed. The patient took the shot not knowing he/she had tick fever, and he/she was alpha gal. The patient believed the COVID shot having tick fever and alpha gal gave the patient autoimmune diseases. The patient did not blame anyone but maybe people can all learn from this, and the patient can start feeling better. The patient had insurance, and the insurance will pay for this. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
Alpha-gal allergy; Tick-borne fever